Ascentage Pharma Group In... (AAPG)
NASDAQ: AAPG
· Real-Time Price · USD
40.48
0.59 (1.48%)
At close: Sep 12, 2025, 10:04 AM
1.48% (1D)
| Bid | 40.35 |
| Market Cap | 3.76B |
| Revenue (ttm) | 980.65M |
| Net Income (ttm) | -405.43M |
| EPS (ttm) | -2.04 |
| PE Ratio (ttm) | -19.84 |
| Forward PE | 45.11 |
| Analyst | n/a |
| Ask | 42.24 |
| Volume | 4,260 |
| Avg. Volume (20D) | 11,333.6 |
| Open | 40.02 |
| Previous Close | 39.89 |
| Day's Range | 40.00 - 40.70 |
| 52-Week Range | 16.50 - 48.45 |
| Beta | 0.92 |
About AAPG
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol AAPG
Website n/a
3 weeks ago
+5.53%
Ascentage Pharma Group shares are trading higher a...
Unlock content with
Pro Subscription
3 months ago
+10.03%
Ascentage Pharma shares are trading higher after the company highlighted new clinical data of Alrizomadlin at ASCO 2025.
